102 related articles for article (PubMed ID: 8914419)
1. [Chemotherapy with low-dose consecutive cisplatin (CDDP) for patients with recurrent and distant metastasis of head and neck cancer].
Nishino H; Abe K; Igarashi M; Miyata M; Kitamura K
Nihon Jibiinkoka Gakkai Kaiho; 1996 Sep; 99(9):1218-22. PubMed ID: 8914419
[TBL] [Abstract][Full Text] [Related]
2. Docetaxel, cisplatin, and fluorouracil for patients with inoperable recurrent or metastatic head and neck squamous cell carcinoma.
Cho H; Nishiike S; Yamamoto Y; Takenaka Y; Nakahara S; Yasui T; Hanamoto A; Inohara H
Auris Nasus Larynx; 2015 Oct; 42(5):396-400. PubMed ID: 25721854
[TBL] [Abstract][Full Text] [Related]
3. Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Shin DM; Glisson BS; Khuri FR; Hong WK; Lippman SM
Semin Oncol; 1998 Apr; 25(2 Suppl 4):40-4; discussion 45-8. PubMed ID: 9578061
[TBL] [Abstract][Full Text] [Related]
4. Ifosfamide, cisplatin, and 13-Cis retinoic acid for patients with advanced or recurrent squamous cell carcinoma of the head and neck: a phase I-II study.
Recchia F; Lalli A; Lombardo M; De Filippis S; Saggio G; Fabbri F; Rosselli M; Capomolla E; Rea S
Cancer; 2001 Aug; 92(4):814-21. PubMed ID: 11550152
[TBL] [Abstract][Full Text] [Related]
5. [Chemotherapy for unresectable recurrent or metastatic squamous cell carcinomas of the head and neck].
Nishino H; Fujisawa Y; Kanazawa T; Ishikawa K; Miyata M; Ichimura K; Abe K; Tanaka H
Nihon Jibiinkoka Gakkai Kaiho; 2000 Sep; 103(9):963-9. PubMed ID: 11070972
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel and cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma.
Adamo V; Ferraro G; Pergolizzi S; Sergi C; Laudani A; Settineri N; Alafaci E; Scimone A; Spano F; Spitaleri G
Oral Oncol; 2004 May; 40(5):525-31. PubMed ID: 15006626
[TBL] [Abstract][Full Text] [Related]
7. Phase I/II study of s-1 plus cisplatin combination chemotherapy in patients with advanced/recurrent head and neck cancer.
Fujii M; Tomita K; Nishijima W; Tsukuda M; Hasegawa Y; Ishitoya J; Yamane H; Homma A; Tomita T
Jpn J Clin Oncol; 2010 Mar; 40(3):214-21. PubMed ID: 19934112
[TBL] [Abstract][Full Text] [Related]
8. [Combination chemotherapy with 5-FU and CDDP or CDDP analog for head and neck cancer].
Fujii M; Ohno Y; Tokumaru Y; Imanishi Y; Kanke M
Gan To Kagaku Ryoho; 1996 Nov; 23(13):1740-6. PubMed ID: 8937483
[TBL] [Abstract][Full Text] [Related]
9. Feasibility study of single agent Cisplatin and concurrent radiotherapy in Japanese patients with squamous cell carcinoma of the head and neck: preliminary results.
Zenda S; Onozawa Y; Tahara M; Kawashima M; Shikama N; Sasaki S; Boku N
Jpn J Clin Oncol; 2007 Oct; 37(10):725-9. PubMed ID: 17925299
[TBL] [Abstract][Full Text] [Related]
10. [Low-dose CDDP and 5-FU for head and neck cancer patients].
Fujii M; Kanke M; Tomita T
Gan To Kagaku Ryoho; 1999 Oct; 26(11):1542-7. PubMed ID: 10553410
[TBL] [Abstract][Full Text] [Related]
11. [Combined chemotherapy with low-dose cisplatin, tegafur and uracil for head and neck squamous cell carcinomas].
Nishino H; Abe K; Ishikawa K; Kanazawa T; Tanaka H; Miyata M; Kitamura K; Morita M
Gan To Kagaku Ryoho; 1999 Oct; 26(11):1617-21. PubMed ID: 10553420
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma.
Shin DM; Glisson BS; Khuri FR; Ginsberg L; Papadimitrakopoulou V; Lee JJ; Lawhorn K; Gillenwater AM; Ang KK; Clayman GL; Callender DL; Hong WK; Lippman SM
J Clin Oncol; 1998 Apr; 16(4):1325-30. PubMed ID: 9552033
[TBL] [Abstract][Full Text] [Related]
13. A prospective evaluation of 5-fluorouracil plus cisplatin in advanced squamous-cell cancer of the head and neck.
Dasmahapatra KS; Citrin P; Hill GJ; Yee R; Mohit-Tabatabai MA; Rush BF
J Clin Oncol; 1985 Nov; 3(11):1486-9. PubMed ID: 4056841
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral cisplatin/epinephrine gel in advanced head and neck cancer: a multicenter, randomized, double-blind, phase III study in North America.
Castro DJ; Sridhar KS; Garewal HS; Mills GM; Wenig BL; Dunphy FR; Costantino PD; Leavitt RD; Stewart ME; Orenberg EK
Head Neck; 2003 Sep; 25(9):717-31. PubMed ID: 12953307
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin, 5-fluorouracil, and high-dose oral leucovorin for advanced head and neck cancer.
Vokes EE; Schilsky RL; Weichselbaum RR; Guaspari A; Guarnieri CM; Whaling SM; Panje WR
Cancer; 1989 Mar; 63(6 Suppl):1048-53. PubMed ID: 2783881
[TBL] [Abstract][Full Text] [Related]
16. Clinical phase II evaluation of paclitaxel in combination with cisplatin in metastatic or recurrent squamous cell carcinoma of the head and neck.
Thödtmann F; Theiss F; Kemmerich M; Heinrich B; Laubenbacher C; Quasthoff S; Kau R; Herzog M; Diergarten K; Hanauske AR
Ann Oncol; 1998 Mar; 9(3):335-7. PubMed ID: 9602270
[TBL] [Abstract][Full Text] [Related]
17. Recurrent and/or metastatic head and neck squamous cell carcinoma: a clinical, univariate and multivariate analysis of response and survival with cisplatin-based chemotherapy.
Recondo G; Armand JP; Tellez-Bernal E; Domenge C; Belehradek M; De Vathaire F; Wibault P; Richard JM; Cvitkovic E
Laryngoscope; 1991 May; 101(5):494-501. PubMed ID: 1709437
[TBL] [Abstract][Full Text] [Related]
18. Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial.
Caponigro F; Di Gennaro E; Ionna F; Longo F; Aversa C; Pavone E; Maglione MG; Di Marzo M; Muto P; Cavalcanti E; Petrillo A; Sandomenico F; Maiolino P; D'Aniello R; Botti G; De Cecio R; Losito NS; Scala S; Trotta A; Zotti AI; Bruzzese F; Daponte A; Calogero E; Montano M; Pontone M; De Feo G; Perri F; Budillon A
BMC Cancer; 2016 Nov; 16(1):918. PubMed ID: 27884140
[TBL] [Abstract][Full Text] [Related]
19. The role of low dose cisplatin plus 5-fluorouracil for treatment of recurrent and/or advanced squamous cell carcinoma of the head and neck.
Kohno N; Kitahara S; Tamura E; Tanabe T; Nakanoboh M; Kawada M; Shirasaka T
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():592-9. PubMed ID: 10895216
[TBL] [Abstract][Full Text] [Related]
20. Systemic chemotherapy with cisplatin plus 5-FU (PF) for recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): efficacy and safety of a lower dose of PF (80/800) at a single institution in Japan.
Kiyota N; Tahara M; Kadowaki S; Fuse N; Doi T; Minami H; Ohtsu A
Jpn J Clin Oncol; 2009 Apr; 39(4):225-30. PubMed ID: 19211574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]